Antimicrobial properties of brevinin-2-related peptide and its analogs: Efficacy against multidrug-resistant acinetobacter baumannii

Chemical Biology and Drug Design

Volumn 74, Issue 5, 2009, Pages 488-493

  Conlon, J Michael ^a   Ahmed, Eman ^a   Condamine, Eric ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Brevinin 2 related peptide; Frog skin

Indexed keywords

A16L PROTEIN; ALANINE; AMINOGLYCOSIDE DERIVATIVE; ASPARTIC ACID; B2RP PROTEIN; BREVININ 2 RELATED PEPTIDE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; COLISTIN; D4K PROTEIN; K16A PROTEIN; L18K PROTEIN; LEUCINE; LYSINE; PEPTIDE; PEPTIDE DERIVATIVE; QUINOLONE DERIVATIVE; SOLVENT; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ALPHA HELIX; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; ERYTHROCYTE; ESCHERICHIA COLI; HEALTH HAZARD; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; MEMBRANE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PUBLIC HEALTH; STAPHYLOCOCCUS AUREUS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMPHIBIAN PROTEINS; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROCYTES; HEMOLYSIS; HUMANS; HYDROPHOBICITY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; OXAZOLES; PEPTIDES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

ACINETOBACTER BAUMANNII; ANURA; CANDIDA ALBICANS; ESCHERICHIA COLI; LITHOBATES; NEGIBACTERIA; RANA SEPTENTRIONALIS; STAPHYLOCOCCUS AUREUS;

EID: 70349741106     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2009.00882.x     Document Type: Article

References (36)

1. Hancock R.E. (2001) Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1 : 156 164.
2. Rinaldi A.C. (2002) Antimicrobial peptides from amphibian skin: an expanding scenario. Current Opin Chem Biol 6 : 799 804.
3. Morikawa N., Hagiwara K., Nakajima T. (1992) Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa. Biochem Biophys Res Commun 189 : 184 190.
4. Conlon J.M., Kolodziejek J., Nowotny N. (2004) Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim Biophys Acta 1696 : 1 14.
5. Conlon J.M., Kolodziejek J., Nowotny N. (2009) Antimicrobial peptides from the skins of North American frogs. Biochim Biophys Acta 1788 : 1556 1563.
6. Bevier C.R., Sonnevend A., Kolodziejek J., Nowotny N., Nielsen P.F., Conlon J.M. (2004) Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog Rana septentrionalis. Comp Biochem Physiol 139C : 31 38.
7. Conlon J.M., Abraham B., Sonnevend A., Jouenne T., Cosette P., Leprince J., Vaudry H., Bevier C.R. (2005) Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). Regul Pept 131 : 38 45.
8. Ashcroft J.W., Zalinger Z.B., Bevier C.R., Fekete F.A. (2007) Antimicrobial properties of two purified skin peptides from the mink frog (Rana septentrionalis) against bacteria isolated from the natural habitat. Comp Biochem Physiol 146C : 325 330.
9. Jain R., Danziger L.H. (2004) Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 38 : 1449 1459.
10. Gootz T.D., Marra A. (2008) Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther 6 : 309 325.
11. Dijkshoorn L., Nemec A., Seifert H. (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5 : 939 951.
12. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., Bonomo R.A. (2007) Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51 : 3471 3484.
13. Karageorgopoulos D.E., Falagas M.E. (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8 : 751 762.
14. Maragakis L.L., Perl T.M. (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46 : 1254 1263.
15. Giacometti A., Cirioni O., Del Prete M.S., Barchiesi F., Paggi A.M., Petrelli E., Scalise G. (2000) Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. J Antimicrob Chemother 46 : 807 810.
16. Turton J.F., Woodford N., Glover J., Yarde S., Kaufmann M.E., Pitt T.L. (2006) Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44 : 2974 2976.
17. Turton J.F., Gabriel S.N., Valderrey C., Kaufmann M.E., Pitt T.L. (2007) Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 13 : 807 815.
18. Conlon J.M., Al-Kharrge R., Ahmed E., Raza H., Galadari S., Condamine E. (2007) Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa. Peptides 28 : 2075 2080.
19. Conlon J.M., Galadari S., Raza H., Condamine E. (2008) Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Chem Biol Drug Des 72 : 58 64.
20. Pace C.N., Vajdos F., Fee L., Grimsley G., Gray T. (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4 : 2411 24223.
21. Clinical Laboratory and Standards Institute (2006) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M07-A8. Wayne, PA : CLSI.
22. Clinical Laboratory and Standards Institute (2006) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Approved Standard M27-A3. Wayne, PA : CLSI.
23. Schiffer M., Edmundson A.B. (1967) Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J 7 : 121 135.
24. Tachi T., Epand R.F., Epand R.M., Matsuzaki K. (2002) Position dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity. Biochemistry 41 : 10723 10731.
25. Kyte J., Doolittle R.F. (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157 : 105 132.
26. Park S., Park S.H., Ahn H.C., Kim S., Kim S.S., Lee B.J., Lee B.J. (2001) Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata. FEBS Lett 507 : 95 100.
27. Shiraki K., Nishikawa K., Goto Y. (1995) Trifluoroethanol-induced stabilization of the alpha-helical structure of beta-lactoglobulin:implication for non-hierarchical protein folding. J Mol Biol 245 : 180 194.
28. Yeaman M.R., Yount N.Y. (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55 : 27 55.
29. Powers J.P., Hancock R.E. (2003) The relationship between peptide structure and antibacterial activity. Peptides 24 : 1681 1691.
30. Wieprecht T., Dathe M., Krause E., Beyermann M., Maloy W.L., MacDonald D.L., Bienert M. (1997) Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett 417 : 135 140.
31. Dathe M., Wieprecht T., Nikolenko H., Handel L., Maloy W.L., MacDonald D.L., Beyermann M., Bienert M. (1997) Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett 403 : 208 212.
32. Kondejewski L.H., Lee D.L., Jelokhani-Niaraki M., Farmer S.W., Hancock R.E., Hodges R.S. (2002) Optimization of microbial specificity in cyclic peptides by modulation of hydrophobicity within a defined structural framework. J Biol Chem 277 : 67 74.
33. Stark M., Liu L.P., Deber C.M. (2002) Cationic hydrophobic peptides with antimicrobial activity. Antimicrob Agents Chemother 46 : 3585 3590.
34. Chen Y., Guarnieri M.T., Vasil A.I., Vasil M.L., Mant C.T., Hodges R.S. (2007) Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother 51 : 1398 1406.
35. Conlon J.M., Al-Ghaferi N., Abraham B., Leprince J. (2007) Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Methods 42 : 349 357.
36. Perron G.G., Zasloff M., Bell G. (2006) Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273 : 251 256.